Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 3 papers. Top paper: “Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS”.
Federico Ivaldi, Elvira Sbragia, Małgorzata Mikulska, Giampaola Pesce, Matilde Inglese +3 more
Federico Ivaldi, Matteo Pardini, Gianluca Rotta, Gemma Vila, Priscilla Bäcker‐Koduah +18 more
Paola Contini, Klaus Schmitz‐Abe, Olga Lanzetta, Feven Getachew, Corinne Bachelin +18 more